Chronic pain, cancer, seizures/epilepsy, and sleep disorders are four major health conditions that millions of people suffer from – and CBD oil may help them all! It’s important to understand why, before getting into how they may help. The National Institutes of Health explains the ECS as, “a recently discovered signaling system comprising the cannabinoid CB1 and CB2 receptors, their intrinsic lipid ligands, endocannabinoids and the associated enzymatic machinery.” The ECS is closely tied to many systems in our body, including the immune system.
- Chronic Pain
Rheumatology described how CBD can help the pain from Rheumatoid Arthritis all the way back in 2006. Seventy-Five patients were screened, and fifty-eight of them were eligible to undergo the study. Thirty-one of them received cannabinoid treatments and twenty-seven received a placebo. The study stated, “In comparison with placebo, the cannabis based medicine produced statistically significant improvements in pain on movement, pain at rest, quality of sleep.” Additionally, there were no serious adverse effects or withdrawals within the treatment group.
Cancer is becoming one of the most studied diseases with CBD. In this study, the focus was on Kaposi sarcoma, a cancer that causes lesions in the soft tissues. The study focused on “infection of endothelial cells (ECs) by Kaposi sarcoma and on the growth and apoptosis of Kaposi sarcoma-infected ECs”. CBD was found to reduce proliferation and induced apoptosis (scheduled cell death) in infected EC’s. CBD also inhibited the expression of certain proteins, receptors, ligands, and vascular endothelial growth factor C, which “suggests a potential mechanism by which CBD exerts its effects on Kaposi sarcoma-infected endothelium.”
- Seizures/ Epilepsy
CBD has become widely known as an extremely effective seizure medication. In this study, 214 people were studied and completed 12 weeks with cannabidiol treatment. All subjects did not respond to current pharmaceutical treatments, and the average age was 11 years old. During the study, seizures decreased by an average of 54%. It should also be noted that only 10% of the people included in the study had minor side effects, including sleepiness, diarrhea, or decreased appetite.
- Sleep disorders
This study was specifically performed on Canadian military personnel with PTSD. A double-blind study was completed using nabilone capsules (NAB), which is a synthetic cannabinoid, or a placebo. They were followed for 7 weeks, then allowed two weeks on their own, and then followed again for 7 more weeks receiving the opposite treatment.
“The mean reduction in nightmares as measured by the CAPS Recurring and Distressing Dream scores were -3.6 ± 2.4 and -1.0 ± 2.1 in the NAB and PBO groups, respectively (p=0.03). Mean global improvement as measured by the Clinical Global Impression of Change (CGI-C) was 1.9 ± 1.1 (i.e. much improved) and 3.2 ± 1.2 (i.e. minimally improved) in the NAB and PBO groups, respectively (p=0.05) Five out of 10 (50%) were much improved on NAB versus 1 out of 9 (11%) on PBO. Results for the General Well Being Questionnaire (WBQ) were 20.8 ± 22 and -0.4 ± 20.6 in the NAB and PBO groups, respectively (p=0.04).”
The study concluded that it showed promise as a clinically-relevant treatment for patients with nightmares and a history of traditional medications not working, as it provided significant relief for military personnel with PTSD.
That’s Natural products contain cannabinoids and terpenes which makes them full spectrum. Each one of us has an endocannabinoid system, which is fueled by these cannabinoids and terpenes. The combination of these compounds help to provide what is known as the entourage effect. By providing pure, potent, and trusted products, That’s Natural continues to strive to meet our customers needs – something we have been doing for over ten years! With 100% traceability of where our hemp comes from, you can be confident in what you are putting on, or in, your body. For more questions regarding our CBD products, please visit our Questions and Answers page.